ArticleAnnals of surgical oncology2026

ASO Author Reflections: Early Tumor Shrinkage: An Early Signal of Benefit From Immune Checkpoint Inhibitors in ESCC.

Keisuke Kosumi et al.PubMed ↗Publisher ↗

No numbers read from the abstract.